[1]
|
Joint United Nations Programme on HIV/AIDS (UNAIDS), “Global Report: UNAIDS Report on the Global AIDS Epidemic 2010,” Geneva, 2010.
|
[2]
|
B. M. Mathers, L. Degenhardt, B. Phillips, L. Wiessing, M. Hickman, S. Strathdee, A. Wodak, et al., “Global Epidemiology of Injecting Drug Use and HIV among People who Inject Drugs: A Systematic Review,” Lancet, Vol. 372, No, 9651, 2008, pp. 1733-1745.
doi:10.1016/S0140-6736(08)61311-2
|
[3]
|
Centers for Diseases Control (CDC), “HIV Prevention Strategic Plan through 2005,” USA, 2001.
|
[4]
|
C. P. Archibald, G. C. Jayaraman, C. Major, D. M. Patrick, S. M. Houston and D. Sutherland, “Estimating the Size of Hand-to-Reach Population: A Novel Method Using HIV Testing Data Compared to Other Methods,” AIDS, Vol. 15, 2001, pp. s41-s48.
doi:10.1097/00002030-200104003-00006
|
[5]
|
J. Weekes and K. Cumberland, “Needle Exchange Programs (NEPs) FAQs,” 2004.
http://www.ccsa.ca/2004%20CCSA%20Documents/ccsa-010055-2004.pdf.Accessed on 11 May 2011
|
[6]
|
Canadian Centre on Substance Abuse, “Injection Drug Users Overview,” 2009, accessed on 11 May 2011.
http://www.ccsa.ca/Eng/Topics/Populations/IDU
|
[7]
|
K. L. DEHNE, M. ADELEKAN, A. CHATTERJEE and G. WEILER, “The Need for a Global Understanding of Epidemiological Data to Inform Human Immunodeficiency Virus (HIV) Prevention among Injecting Drug Users,” Bulletin on Narcotics, Vol. LIV, No. 1-2, 2002, pp. 117- 130.
|
[8]
|
R. Muga, K. Langohr, J. Tor, A. Sanvisens, I. Serra and C. R. Rey-Joly, “Survival of HIV-Infected Injection Drug Users (IDUs) in the Highly Active Antiretroviral Therapy Era, Relative to Sex- and Age-Specific Survival of HIV-Un- infected IDUs,” Clinical Infectious Diseases, Vol. 45, No. 3, 2007, pp.370-376. doi:10.1086/519385
|
[9]
|
Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries, “Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence,” The National Academies Press, Washington, D.C., 2006.
|
[10]
|
D. D. Heckathorn, “Respondent-Driven Sampling: A new Approach to the Study of Hidden Populations,” Social Problems, Vol. 44, No. 2, 1997, pp. 174-199.
doi:10.1525/sp.1997.44.2.03x0221m
|
[11]
|
S. Zhang, P. Yan and C. Archibald, “Estimating the Size of IDU Population Using Needle Exchange Programs,” Proceedings of Statistics Canada Symposium 2004 Innovative Methods for Surveying Difficult-to-Reach Popultions, Statistics Canada, Ottawa, 2004, pp. 1-10.
|
[12]
|
D. D. Heckathorn, “Extensions of Respondent-Driven sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment,” Sociological Methodology, Vol. 31, No. 1, 2007, pp. 151-207.
doi:10.1111/j.1467-9531.2007.00188.x
|
[13]
|
K. J. Gile and M. S. Handcock, “Respondent-Driven sampling: An Assessment of Current Methodology,” Sociological Methodology, Vol. 40, No. 1, 2010, pp. 285-327.
doi:10.1111/j.1467-9531.2010.01223.x
|
[14]
|
M. J. Salganik and D. D. Heckathorn, “Sampling and Estimation in hidden Populations Using Respondent- driven Sampling,” Sociological Methodology, Vol. 34, No. 1, 2004, pp. 193-239.
doi:10.1111/j.0081-1750.2004.00152.x
|
[15]
|
Public Health Agency of Canada, “Harm Reduction and Injection Drug Use: An International Comparative Study of Contextual Factors Influencing the Development and Implementation of Relevant Policies and Program,” 2003, accessed on 18 March 2006.
http://www.phac-aspc.gc.ca/hepc/pubs/hridu-rmudi/index-eng.php
|
[16]
|
C. Strike, L. Leonard, M. Millson, S. Anstice, N. Berkeley and E. Medd, “Ontario Needle Exchange Programs: Best Practice Recommendations,” Toronto: Ontario Needle Exchange Coordinating Committee, 2006.
|
[17]
|
C. L. Miller, M. Tyndall, P. Spittal, K. Li, A. Palepu and M. T. Schechter, “Risk-Taking Behaviors among Injecting Drug Users Who Obtain Syringes from Pharmacies, Fixed Sites, and Mobile Van Needle Exchanges,” Journal of Urban Health, Vol. 79, No. 2, 2002, pp. 257-265.
doi:10.1093/jurban/79.2.257
|
[18]
|
C. Sarndal, B. Swensson and J. Wretman, “Model Assisted Survey Sampling,” Series in Statistics, Springer, New York, 1992.
|
[19]
|
W. G. Cochran, “Sampling Techniques,” 3rd Edition, Wiley, New York, 1977.
|
[20]
|
D. C. DesJarlais, C. McKnight, K. Eigo and P. Friedmann, “2000 United States Syringe Exchange Program Survey,” The Baron Edmond de Rothschild Chemical Dependency Institute, New York, 2000.
|
[21]
|
M. MacDonald, A. D. Wodak, R. Ali, N. Crofts, P. H. Cunningham, K. A. Dolan, M. Kelaher, W. M. Loxley, I. van Beek and J. M. Kaldor, “HIV Prevalence and Risk Behaviour in Needle Exchange Attenders: A National Study. The Collaboration of Australian Needle Exchanges,” The Medecal Journal of Australia, Vol. 166, No. 5, 1997, pp. 237-240.
|
[22]
|
M. Peggy, T. Myers, L. Calzavara, E. Wallace, C. Major, and N. Degani, “Regional Variation in HIV Prevalence and Risk Behaviours in Ontario Injection Drug Users,” Canadian Journal of Public Health, Vol. 94, No. 6, 2003, pp. 431-435.
|
[23]
|
K. Vijayan, “An Exact Sampling Scheme: Generalization of a Method of Hanurav,” Journal of the Royal Statistical Society, Vol. 30, No. 6, 1968, pp. 499-513.
|
[24]
|
K. W. R. Brewer, “A model of systematic sampling with unequal probabilities,” Australian Journal of Statistics, Vol. 5, 1963, pp. 93-105.
doi:10.1111/j.1467-842X.1963.tb00288.x
|
[25]
|
S. M. Roos, “Probability Models,” 6th Edition, Academic Press, London, 1997.
|
[26]
|
E. L. Korn and B. I. Graubard, “Analysis of Health Surveys,” Wiley Series in Probability and Statistics Survey Methodology Section, John Wiley & Sons, New York, 1999. doi:10.1002/9781118032619
|
[27]
|
M. E. Thompson, “Theory of Sample Surveys,” Chapman & Hall, London, 1997.
|
[28]
|
S. L. Lohr, “Sampling: Design and Analysis,” Duxbury Press, New York, 1999.
|
[29]
|
C. Sarndal, B. Swensson and J. Wretman, “Model Assisted Survey Sampling,” Series in Statistics, Springer, New York, 1992.
|